Healthcare and Pharmaceuticals industry

Prostate Cancer Diagnostics Market 2019 By Manufacturers, Regions, Type And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Prostate cancer is a type of cancer that is developed in the prostate gland and it can spread by breaking away from prostate tumors. The prostate gland is found only in men and is located below the bladder. Adenocarcinomas, small cell carcinomas, neuroendocrine tumors (other than small cell carcinomas), transitional cell carcinomas, and sarcomas are a type of prostate cancer. Prostate cancer can be diagnosed by ultrasound, collecting a sample of prostate tissue, MRI fusion, and biopsy.

Rising cases of prostate cancer around the globe is a prime factor fueling market growth. According to the report published in April 2018, by "Our World in Data" in 2017, 9.6 million people are estimated to have died from the various forms of cancer. Every sixth death in the world is due to cancer, making it the second leading cause of death. Moreover, increasing the launch of innovative prostate cancer diagnostic devices is another major factor serving as a growth factor. For instance, in July 2019, Diagnostics developer MDNA Life Sciences has partnered with Aspire Pharma to introduce the new Mitomic Prostate Test (MPT) for clinical use in the UK. The blood test is intended to identify individuals with clinically significant prostate cancer or those who require treatment. It analyses mitochondrial DNA as biomarkers to determine whether a man has or does not have cancer.

From the geographical perspective, North America is expected to gain significant growth over the forecast period and this can be attributed to the high prevalence of prostate cancer in the region. According to the U.S. Department of Health and Human Services, in 2019, the number of new cases of prostate cancer was 174,650 and death case was approx. 31,620.

However, the high cost of the diagnosis and treatment of prostate cancer is expected to hamper the market growth.

Key Developments

• In September 2019, the Food and Drug Administration approved apalutamide (ERLEADA, Janssen Biotech, Inc) for patients with metastatic castration-sensitive prostate cancer (mCSPC).

• In October 2019, GE Healthcare has formed a global alliance with Theragnostics for the commercialization of a prostate-specific membrane antigen (PSMA) PET / CT imaging agent, GalliProst. The diagnostic is designed to help visualize prostate cancer, offering information on the status of the disease and allowing personalized treatment.

• In September 2019, Koelis SAS (“Koelis” or the “Company”) and InnovaHealth Partners, LP (“InnovaHealth”) jointly announced today along with Medevice Partners (“Medevice”). Koelis is a leading innovator in the market for image-guided systems for prostate cancer diagnosis and treatment.

World economic growth, the Prostate Cancer Diagnostics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Prostate Cancer Diagnostics market size to maintain the average annual growth rate of 0.0506911866246 from 8200.0 million $ in 2014 to 10500.0 million $ in 2020, Stratagem Market Insights analysts believe that in the next few years, Prostate Cancer Diagnostics market size will be further expanded, we expect that by 2026, The market size of the Prostate Cancer Diagnostics will reach 14900.0 million $.

This Report covers the manufacturers' data, including shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the World, which shows a regional development status, including market size, volume, and value, as well as price data.

Besides, the report also covers segment data, including type segment, industry segment, channel segment, etc. cover different segment market size, both volume, and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information,

Section 1: Definition

Section (2 3): Manufacturer Detail

Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
BioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Section 4: Region Segmentation

North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

Section (5 6 7): Segmentation

Product Type Segmentation:
Tumor Biomarker Tests
Imaging
Biopsy

Industry Segmentation:
age < 55
age 55-75
age > 75

Channel (Direct Sales, Distributor) Segmentation

Section 8: Trend (2020-2026)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion

Table of Contents
Section 1 Prostate Cancer Diagnostics Product Definition

Section 2 Global Prostate Cancer Diagnostics Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Prostate Cancer Diagnostics Shipments
2.2 Global Manufacturer Prostate Cancer Diagnostics Business Revenue
2.3 Global Prostate Cancer Diagnostics Market Overview

Section 3 Manufacturer Prostate Cancer Diagnostics Business Introduction
3.1 Genomic Health Prostate Cancer Diagnostics Business Introduction
3.1.1 Genomic Health Prostate Cancer Diagnostics Shipments, Price, Revenue and Gross profit 2014-2018
3.1.2 Genomic Health Prostate Cancer Diagnostics Business Distribution by Region
3.1.3 Genomic Health Interview Record
3.1.4 Genomic Health Prostate Cancer Diagnostics Business Profile
3.1.5 Genomic Health Prostate Cancer Diagnostics Product Specification

3.2 Abbott Prostate Cancer Diagnostics Business Introduction
3.2.1 Abbott Prostate Cancer Diagnostics Shipments, Price, Revenue and Gross profit 2014-2018
3.2.2 Abbott Prostate Cancer Diagnostics Business Distribution by Region
3.2.3 Interview Record
3.2.4 Abbott Prostate Cancer Diagnostics Business Overview
3.2.5 Abbott Prostate Cancer Diagnostics Product Specification

3.3 OPKO Prostate Cancer Diagnostics Business Introduction
3.3.1 OPKO Prostate Cancer Diagnostics Shipments, Price, Revenue and Gross profit 2014-2018
3.3.2 OPKO Prostate Cancer Diagnostics Business Distribution by Region
3.3.3 Interview Record
3.3.4 OPKO Prostate Cancer Diagnostics Business Overview
3.3.5 OPKO Prostate Cancer Diagnostics Product Specification

3.4 Siemens Healthcare Prostate Cancer Diagnostics Business Introduction
3.5 DiaSorin Prostate Cancer Diagnostics Business Introduction
3.6 BioMeriux Prostate Cancer Diagnostics Business Introduction


Section 4 Global Prostate Cancer Diagnostics Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.1.2 Canada Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.2 South America Country
4.2.1 South America Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.3 Asia Country
4.3.1 China Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.3.2 Japan Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.3.3 India Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.3.4 Korea Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.4 Europe Country
4.4.1 Germany Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.4.2 UK Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.4.3 France Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.4.4 Italy Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.4.5 Europe Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.5 Other Country and Region
4.5.1 Middle East Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.5.2 Africa Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.5.3 GCC Prostate Cancer Diagnostics Market Size and Price Analysis 2014-2018
4.6 Global Prostate Cancer Diagnostics Market Segmentation (Region Level) Analysis 2014-2018
4.7 Global Prostate Cancer Diagnostics Market Segmentation (Region Level) Analysis

Section 5 Global Prostate Cancer Diagnostics Market Segmentation (Product Type Level)
5.1 Global Prostate Cancer Diagnostics Market Segmentation (Product Type Level) Market Size 2014-2018
5.2 Different Prostate Cancer Diagnostics Product Type Price 2014-2018
5.3 Global Prostate Cancer Diagnostics Market Segmentation (Product Type Level) Analysis

Section 6 Global Prostate Cancer Diagnostics Market Segmentation (Industry Level)
6.1 Global Prostate Cancer Diagnostics Market Segmentation (Industry Level) Market Size 2014-2018
6.2 Different Industry Price 2014-2018
6.3 Global Prostate Cancer Diagnostics Market Segmentation (Industry Level) Analysis

Section 7 Global Prostate Cancer Diagnostics Market Segmentation (Channel Level)
7.1 Global Prostate Cancer Diagnostics Market Segmentation (Channel Level) Sales Volume and Share 2014-2018
7.2 Global Prostate Cancer Diagnostics Market Segmentation (Channel Level) Analysis

Section 8 Prostate Cancer Diagnostics Market Forecast 2018-2023
8.1 Prostate Cancer Diagnostics Segmentation Market Forecast (Region Level)
8.2 Prostate Cancer Diagnostics Segmentation Market Forecast (Product Type Level)
8.3 Prostate Cancer Diagnostics Segmentation Market Forecast (Industry Level)
8.4 Prostate Cancer Diagnostics Segmentation Market Forecast (Channel Level)

Section 9 Prostate Cancer Diagnostics Segmentation Product Type
9.1 Tumor Biomarker Tests Product Introduction
9.2 Imaging Product Introduction
9.3 Biopsy Product Introduction

Section 10 Prostate Cancer Diagnostics Segmentation Industry
10.1 age < 55 Clients
10.2 age 55-75 Clients
10.3 age > 75 Clients

Section 11 Prostate Cancer Diagnostics Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview

Section 12 Conclusion

Chart and Figure
Figure Prostate Cancer Diagnostics Product Picture from Genomic Health
Chart 2014-2018 Global Manufacturer Prostate Cancer Diagnostics Shipments (Units)
Chart 2014-2018 Global Manufacturer Prostate Cancer Diagnostics Shipments Share
Chart 2014-2018 Global Manufacturer Prostate Cancer Diagnostics Business Revenue (Million USD)
Chart 2014-2018 Global Manufacturer Prostate Cancer Diagnostics Business Revenue Share
Chart Genomic Health Prostate Cancer Diagnostics Shipments, Price, Revenue and Gross profit 2014-2018
Chart Genomic Health Prostate Cancer Diagnostics Business Distribution
Chart Genomic Health Interview Record (Partly)
Figure Genomic Health Prostate Cancer Diagnostics Product Picture
Chart Genomic Health Prostate Cancer Diagnostics Business Profile
Table Genomic Health Prostate Cancer Diagnostics Product Specification
Chart Abbott Prostate Cancer Diagnostics Shipments, Price, Revenue and Gross profit 2014-2018
Chart Abbott Prostate Cancer Diagnostics Business Distribution
Chart Abbott Interview Record (Partly)
Figure Abbott Prostate Cancer Diagnostics Product Picture
Chart Abbott Prostate Cancer Diagnostics Business Overview
Table Abbott Prostate Cancer Diagnostics Product Specification
Chart OPKO Prostate Cancer Diagnostics Shipments, Price, Revenue and Gross profit 2014-2018
Chart OPKO Prostate Cancer Diagnostics Business Distribution
Chart OPKO Interview Record (Partly)
Figure OPKO Prostate Cancer Diagnostics Product Picture
Chart OPKO Prostate Cancer Diagnostics Business Overview
Table OPKO Prostate Cancer Diagnostics Product Specification
3.4 Siemens Healthcare Prostate Cancer Diagnostics Business Introduction

Chart United States Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart United States Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart Canada Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Canada Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart South America Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart South America Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart China Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart China Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart Japan Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Japan Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart India Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart India Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart Korea Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Korea Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart Germany Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Germany Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart UK Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart UK Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart France Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart France Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart Italy Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Italy Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart Europe Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Europe Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart Middle East Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Middle East Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart Africa Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart Africa Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart GCC Prostate Cancer Diagnostics Sales Volume (Units) and Market Size (Million $) 2014-2018
Chart GCC Prostate Cancer Diagnostics Sales Price ($/Unit) 2014-2018
Chart Global Prostate Cancer Diagnostics Market Segmentation (Region Level) Sales Volume 2014-2018
Chart Global Prostate Cancer Diagnostics Market Segmentation (Region Level) Market size 2014-2018
Chart Prostate Cancer Diagnostics Market Segmentation (Product Type Level) Volume (Units) 2014-2018
Chart Prostate Cancer Diagnostics Market Segmentation (Product Type Level) Market Size (Million $) 2014-2018
Chart Different Prostate Cancer Diagnostics Product Type Price ($/Unit) 2014-2018
Chart Prostate Cancer Diagnostics Market Segmentation (Industry Level) Market Size (Volume) 2014-2018
Chart Prostate Cancer Diagnostics Market Segmentation (Industry Level) Market Size (Share) 2014-2018
Chart Prostate Cancer Diagnostics Market Segmentation (Industry Level) Market Size (Value) 2014-2018
Chart Global Prostate Cancer Diagnostics Market Segmentation (Channel Level) Sales Volume (Units) 2014-2018
Chart Global Prostate Cancer Diagnostics Market Segmentation (Channel Level) Share 2014-2018
Chart Prostate Cancer Diagnostics Segmentation Market Forecast (Region Level) 2018-2023
Chart Prostate Cancer Diagnostics Segmentation Market Forecast (Product Type Level) 2018-2023
Chart Prostate Cancer Diagnostics Segmentation Market Forecast (Industry Level) 2018-2023
Chart Prostate Cancer Diagnostics Segmentation Market Forecast (Channel Level) 2018-2023
Chart Tumor Biomarker Tests Product Figure
Chart Tumor Biomarker Tests Product Advantage and Disadvantage Comparison
Chart Imaging Product Figure
Chart Imaging Product Advantage and Disadvantage Comparison
Chart Biopsy Product Figure
Chart Biopsy Product Advantage and Disadvantage Comparison
Chart age < 55 Clients
Chart age 55-75 Clients
Chart age > 75 Clients

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.